Similar articles

• Pathogenesis of thyroid-associated ophthalmopathy.

  Salvi M, Hiromatsu Y, Bernard N, How J, Wall JR. Salvi M, et al. Dev Ophthalmol. 1989;20:58-67. doi: 10.1159/000417920. Dev Ophthalmol. 1989. PMID: 2591628 No abstract available.
• Ophthalmopathy and thyroid disorders.

  [No authors listed] [No authors listed] N Engl J Med. 1977 Apr 28;296(17):1002-3. doi: 10.1056/NEJM197704282961715. N Engl J Med. 1977. PMID: 576726 No abstract available.
• [Endocrine ophthalmopathy and autoimmune thyroid disease].

  Karlsson A, Dahlberg PA, Enoksson P, Boström L, Sääf M, Sjöberg HE, Tallstedt L. Karlsson A, et al. Nord Med. 1985;100(11):298-301. Nord Med. 1985. PMID: 3840885 Swedish. No abstract available.
• Dermatologic aspects of thyroid disease.

  Burman KD, McKinley-Grant L. Burman KD, et al. Clin Dermatol. 2006 Jul-Aug;24(4):247-55. doi: 10.1016/j.clindermatol.2006.04.010. Clin Dermatol. 2006. PMID: 16828405 Review.
• Pathogenesis of Graves' ophthalmopathy.

  Gorman CA, Bahn RS. Gorman CA, et al. Dev Ophthalmol. 1989;20:1-7. Dev Ophthalmol. 1989. PMID: 2687045 Review. No abstract available.